← All stocks

Rani Therapeutics Holdings, Inc.

RANI Net selling
CIK 0001856725 #4228 in the set updated 18 Sep 2026
Bought (12 mo)
$1.31M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$15.71M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$15.71M
3 of 3 sales
Net
−$14.40M
−$14.40M against sales at will

By person

5 insiders · 6 transactions
0.6×

Talat Imran holds only 0.6 times base salary in stock. $324.12K of shares against $502.18K in salary for 2025.

Salary from the company's own proxy. The shares are what Talat Imran last reported holding, valued at $0.69, the price Class A Common Stock was last bought or sold at on the open market here, on 21 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
South Cone Investments Limited Partnership entity
10% owner
$15.71M (2)
−$15.71M
2,379,194
$1.64M
−80.4%
IMRAN MIR A
Director
$1.29M (2)
+$1.29M
2,119,334
$1.46M
Imran Talat
Chief Executive Officer
$25.19K (1)
+$25.19K
469,736
$324.12K
−3.0%
Javadi Alireza
Chief Technical Officer
$301.08 (1)
−$301.08
9,380
$6.47K
−6.9%
McKinley Kate
Chief Business Officer
17,960
$12.39K

No percentages here. This company's share count has moved by a factor of 6.5 over the window, from 28,836,000 to 187,168,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
IMRAN MIR A
21 Jul 2026
Director
Buy
36,000
$0.69
$24.84K
Imran Talat
17 Jul 2026
Chief Executive Officer
Buy
35,000
$0.72
$25.19K
IMRAN MIR A
23 Oct 2025
Director
Buy
2,083,334
$0.61
$1.26M

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 43,234
History held since 3 Aug 2021